Journal Pre-proof Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India Aloke Ghoshal, Pradyut Waghray, George Dsouza, Mahip Saluja, Mayank Agarwal, Ashish Goyal, Sneha Limaye, Akash Balki, Sudhir Bhatnagar, Manish Jain, Sharad Tikkiwal, Abhijit Vaidya, Meena Lopez, Rashmi Hegde, Jaideep Gogtay PII: S1094-5539(19)30184-1 DOI: https://doi.org/10.1016/j.pupt.2019.101869 Reference: YPUPT 101869 To appear in: Pulmonary Pharmacology & Therapeutics Received Date: 13 August 2019 Revised Date: 25 November 2019 Accepted Date: 25 November 2019 Please cite this article as: Ghoshal A, Waghray P, Dsouza G, Saluja M, Agarwal M, Goyal A, Limaye S, Balki A, Bhatnagar S, Jain M, Tikkiwal S, Vaidya A, Lopez M, Hegde R, Gogtay J, Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India, Pulmonary Pharmacology & Therapeutics (2019), doi: https://doi.org/10.1016/ j.pupt.2019.101869. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Ltd.